Mondelez International
MDLZ
$57.68
-2.24%
Mondelez International is a global leader in the snack food industry, operating primarily in the biscuit, chocolate, gum/candy, beverage, and cheese and grocery aisles with iconic brands like Oreo, Cadbury, and Chips Ahoy. The company is a dominant market player with a vast international footprint, deriving significant revenue from developing markets, Europe, and North America, which provides geographic diversification and scale advantages. The current investor narrative centers on the stock's defensive characteristics and reliable dividend amidst a challenging market environment, as evidenced by its recent declaration of a steady quarterly dividend, though its performance has been pressured by significant underperformance relative to the broader market over the past year.…
MDLZ
Mondelez International
$57.68
Investment Opinion: Should I buy MDLZ Today?
Rating & Thesis: Hold. Mondelez is a high-quality defensive company caught in a valuation reset, with its reliable dividend and cash flow offset by earnings volatility and significant technical underperformance, making it unsuitable for aggressive buying until profitability stabilizes. This aligns with the mixed but generally neutral analyst sentiment, where the stock's current price offers limited immediate upside to consensus targets without a clear catalyst.
Supporting Evidence: The primary valuation metric, the forward P/E of 17.51x, suggests the market expects earnings growth, but this is juxtaposed against a high trailing P/E of 28.42x and a negative PEG ratio of -0.63. Revenue growth of 9.29% YoY in Q4 is solid, yet profitability is highly volatile, with net margin swinging over 11 percentage points year-over-year. The stock trades at a Price-to-Sales of 1.81x and an EV/EBITDA of 19.32x, which, in the absence of direct peer averages, appear full given the growth profile. The implied upside is muted as the stock trades near the lower end of its 52-week range.
Risks & Conditions: The two biggest risks are continued margin pressure invalidating the forward earnings estimates and persistent technical weakness leading to further multiple compression. This Hold rating would upgrade to a Buy if the forward P/E compressed below 15x alongside evidence of margin stabilization, or if the stock sustained a breakout above its 52-week high resistance of $71.15. It would downgrade to a Sell if revenue growth decelerated below 5% or if the stock broke decisively below its 52-week low of $51.20. Currently, the stock appears fairly valued to slightly overvalued relative to its own volatile earnings history, demanding a wait-and-see approach.
Sign up to view all
MDLZ 12-Month Price Forecast
MDLZ presents a conflicted profile: its underlying business is solid with strong brands and cash flow, but the stock is penalized for earnings volatility and poor relative performance. The forward P/E suggests the market has already adjusted expectations downward, providing a valuation floor, but a catalyst for multiple expansion is absent without proof of sustained margin recovery. The stance is neutral with medium confidence, as the path of least resistance appears to be sideways consolidation. An upgrade to bullish would require two consecutive quarters of margin expansion and a technical breakout above $65. A downgrade to bearish would be triggered by a breakdown below the $51.20 support level.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Mondelez International's 12-month outlook, with a consensus price target around $74.98 and implied upside of +30.0% versus the current price.
Average Target
$74.98
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$46 - $75
Analyst target range
Mondelez is covered by a limited set of six analysts, with consensus estimates for EPS averaging $4.06 and revenue averaging $44.24 billion, indicating expectations for steady financial performance. The institutional ratings data shows a mixed but generally neutral-to-positive sentiment, with recent actions including a downgrade from Rothschild & Co from Buy to Neutral, while firms like Morgan Stanley, Bernstein, Wells Fargo, and Stifel maintain Overweight/Outperform/Buy ratings. The wide range of analyst actions, from downgrades to reiterated bullish calls, signals moderate uncertainty and debate regarding the stock's near-term catalysts and valuation, which is typical for a large-cap defensive name in a transitioning economic environment.
Bulls vs Bears: MDLZ Investment Factors
The evidence currently tilts bearish, primarily due to MDLZ's severe and sustained underperformance relative to the market, coupled with significant earnings volatility that has not been fully reflected in its still-elevated trailing valuation. The bull case rests on the company's defensive characteristics, strong cash flow, and the valuation discount implied by its forward P/E. The single most important tension in the investment debate is whether the stock's current price near its 52-week low represents a compelling value entry for a high-quality defensive name, or if it is a value trap facing persistent margin pressure and growth headwinds that will continue to compress multiples. The resolution of this tension depends on whether Q4 2025's 9.29% revenue growth can be sustained alongside a stabilization in profitability.
Bullish
- Strong Free Cash Flow Supports Dividend: Mondelez generates robust free cash flow of $3.235 billion TTM, providing a solid foundation for its reliable $0.50 quarterly dividend. However, the current payout ratio of 101.47% indicates the dividend is fully covered but leaves minimal room for error, requiring sustained cash generation.
- Defensive Profile with Low Beta: The stock's beta of 0.389 makes it approximately 61% less volatile than the broader market, a key defensive characteristic. This low volatility is attractive for risk-averse investors seeking stability, especially after the stock's 10.58% annual decline underperformed the S&P 500 by nearly 40 percentage points.
- Solid Revenue Growth in Latest Quarter: Q4 2025 revenue grew 9.29% year-over-year to $10.496 billion, demonstrating resilience in its core snack categories. This growth, driven by its diversified brand portfolio across biscuits (48% of sales) and chocolate (33%), shows the company's pricing power and global reach.
- Analyst Consensus Remains Positive: Despite recent underperformance, analyst sentiment is mixed but leans positive, with firms like Morgan Stanley and Bernstein maintaining Overweight/Buy ratings. The average analyst revenue estimate for the coming year is $44.24 billion, signaling expectations for steady performance.
Bearish
- Severe Price Underperformance vs. Market: MDLZ has significantly underperformed the broader market, down 10.58% over the past year versus the S&P 500's 29.52% gain, resulting in a stark -40.10 relative strength. This persistent downtrend, with the stock trading near 30% of its 52-week range, reflects deep investor skepticism.
- Earnings Volatility and Margin Pressure: Profitability has been highly volatile, with Q4 2025 net income of $665 million (6.36% margin) down sharply from $1.745 billion (18.17% margin) in Q4 2024. The gross margin of 28.16% is consistent but reflects ongoing input cost pressures in the consumer staples sector.
- Elevated Trailing P/E Despite Weakness: Even after the significant price decline, the trailing P/E of 28.42x remains elevated compared to its own historical levels (e.g., 11.45x at end of Q4 2024). This suggests the stock's valuation has not fully reset to reflect the earnings compression and growth challenges.
- Tight Liquidity and High Payout Ratio: The current ratio of 0.59 indicates somewhat tight short-term liquidity, which could limit financial flexibility. Coupled with a dividend payout ratio exceeding 100%, this raises questions about the sustainability of capital returns if free cash flow generation falters.
MDLZ Technical Analysis
The prevailing price trend for Mondelez is a sustained downtrend, with the stock down 10.579% over the past year, significantly underperforming the S&P 500's 29.52% gain, as indicated by a stark -40.099 relative strength. Currently trading at $59, the stock sits at approximately 29.8% of its 52-week range ($51.2 to $71.15), positioning it much closer to its annual low, which suggests it may be approaching a potential value zone but also reflects persistent selling pressure. Recent momentum shows a notable divergence, with the stock up 6.5751% over the past month and 7.0975% over three months, indicating a potential short-term recovery or consolidation phase after the severe longer-term decline, though this nascent rebound has not yet challenged the dominant downtrend. Key technical levels are clearly defined by the 52-week low of $51.2 as critical support and the 52-week high of $71.15 as major resistance; a breakdown below $51.2 would signal a new leg down, while a sustained move above resistance is needed to suggest a trend reversal. The stock's beta of 0.389 indicates it is approximately 61% less volatile than the broader market, which aligns with its defensive sector but also implies limited explosive upside potential during market rallies.
Beta
0.39
0.39x market volatility
Max Drawdown
-27.2%
Largest decline past year
52-Week Range
$51-$71
Price range past year
Annual Return
-14.0%
Cumulative gain past year
| Period | MDLZ Return | S&P 500 |
|---|---|---|
| 1m | +5.1% | +3.6% |
| 3m | +3.1% | -1.1% |
| 6m | -6.5% | +3.1% |
| 1y | -14.0% | +28.5% |
| ytd | +7.5% | +0.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MDLZ Fundamental Analysis
Mondelez's revenue trajectory shows solid growth, with Q4 2025 revenue of $10.496 billion representing a 9.29% year-over-year increase, though this follows a period of more volatile quarterly performance as seen in the income statement data. The company's biscuit segment, contributing $4.686 billion, remains the largest revenue driver, while chocolate ($3.777 billion) and gum/candy ($1.089 billion) are other significant contributors, providing a diversified portfolio of staple snack categories. The company is consistently profitable, with Q4 2025 net income of $665 million and a net margin of 6.36%, though profitability has fluctuated significantly quarter-to-quarter, with Q4 2024 showing a much higher net income of $1.745 billion and margin of 18.17%, indicating potential normalization or one-time impacts. Gross margin for the latest quarter was 28.16%, which is consistent with the trailing twelve-month gross margin of 28.01% from valuation data, suggesting stable input cost management in a challenging environment for consumer staples. The balance sheet and cash flow position is robust, with a debt-to-equity ratio of 0.867 and a current ratio of 0.592, indicating manageable leverage but somewhat tight short-term liquidity. Strong free cash flow generation is a key strength, with TTM free cash flow of $3.235 billion supporting the company's dividend, which had a payout ratio of 101.47% in the latest period, and a return on equity of 9.49% demonstrates adequate, if not spectacular, returns on shareholder capital.
Quarterly Revenue
$10.5B
2025-12
Revenue YoY Growth
+0.09%
YoY Comparison
Gross Margin
+0.28%
Latest Quarter
Free Cash Flow
$3.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MDLZ Overvalued?
Given Mondelez's positive net income, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 28.42x, which is significantly higher than its forward PE of 17.51x, indicating the market expects substantial earnings growth in the coming year to justify the current price. Compared to sector averages, Mondelez's trailing PE of 28.42x and forward PE of 17.51x are not directly comparable without a provided industry average, but its Price-to-Sales ratio of 1.81x and EV/EBITDA of 19.32x provide alternative valuation context in the absence of peer data. Historically, the stock's current trailing PE of 28.42x sits above its own recent historical range observed in the data, such as the 26.09x at the end of Q4 2025 and the 11.45x at the end of Q4 2024, suggesting the market may still be pricing in a recovery premium despite the recent price decline, or that earnings have compressed faster than the share price.
PE
28.4x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 11x~55x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
19.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Mondelez faces clear profitability risks, with net income plummeting from $1.745 billion in Q4 2024 to $665 million in Q4 2025, representing a margin compression from 18.17% to 6.36%. This earnings volatility, potentially driven by input cost inflation and one-time items, challenges the stability expected from a defensive stock. Furthermore, the dividend payout ratio of 101.47%, while supported by strong TTM free cash flow of $3.235 billion, operates with no margin of safety, and the current ratio of 0.59 indicates limited liquidity buffers for unforeseen operational stresses.
Market & Competitive Risks: The primary market risk is valuation compression. Despite a 10.58% annual decline, the trailing P/E of 28.42x remains high relative to the stock's own history, suggesting further multiple contraction is possible if growth expectations are not met. The stock's low beta of 0.389, while defensive, also implies it may continue to lag during broad market rallies, as evidenced by its -40.10 relative strength over the past year. Competitive and regulatory pressures in the global snack food industry could further pressure already volatile margins.
Worst-Case Scenario: The worst-case scenario involves a continuation of margin erosion coupled with a growth slowdown, triggering multiple compression and a flight from defensive stocks in a risk-on market. This could see the stock re-test and break below its 52-week low of $51.20. Given the stock's max drawdown of -27.19% and its current price of $59, a realistic adverse scenario could see a decline of approximately 13-15% to the $50-$52 range, representing a loss of roughly $8-$9 per share from current levels.
FAQ
The key risks are, in order of severity: 1) Profitability Risk: Extreme earnings volatility, with Q4 2025 net income down 62% year-over-year, challenging the defensive narrative. 2) Valuation Compression Risk: The high trailing P/E of 28.42x is vulnerable to further contraction if growth stalls. 3) Market Risk: Persistent underperformance (relative strength -40.10) may continue, especially in a rising market, due to its low beta. 4) Financial Flexibility Risk: A tight current ratio of 0.59 and a dividend payout ratio over 100% limit the margin for operational error.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $59 and $65, as it consolidates with stable cash flows but muted growth. The Bull Case (25% probability) targets $68 to $71, requiring a margin recovery and renewed investor favor. The Bear Case (15% probability) warns of a drop to $51-$55 if profitability deteriorates further. The most likely scenario is the Base Case, which assumes the company's solid fundamentals prevent a crash, but earnings volatility prevents a significant rally. The key assumption is that net margins stabilize from their current depressed level of 6.36%.
MDLZ's valuation sends mixed signals, leaning towards fair value to slightly overvalued based on recent performance. The trailing P/E of 28.42x is elevated, especially compared to the stock's own P/E of 11.45x a year ago, suggesting the market has been slow to adjust to lower earnings. The forward P/E of 17.51x implies the market expects a significant earnings recovery. Compared to sector averages (not provided), its Price-to-Sales of 1.81x and EV/EBITDA of 19.32x appear full for a company with volatile margins. Overall, the market is paying a fair price for expected future improvement, but no clear discount exists given the operational uncertainties.
MDLZ is not a compelling buy at current levels for most investors seeking growth or near-term outperformance. The stock has significantly underperformed the market (-10.58% vs. S&P 500 +29.52%), and its earnings are highly volatile. However, for a specific investor profile—such as a conservative, income-oriented investor seeking low volatility (beta 0.389) and a reliable dividend supported by $3.2B in annual free cash flow—it could represent a steady, if unexciting, holding. The decision hinges on whether one believes the forward P/E of 17.5x adequately prices in the risks of further margin pressure.
MDLZ is unequivocally more suitable for a long-term investment horizon. Its low beta and dividend focus are attributes that compound value over time, not drivers of short-term trading gains. The stock's significant underperformance and lack of a clear near-term catalyst make it a poor candidate for short-term trading. Given the need to see through the current earnings volatility and allow for a potential valuation reset, a minimum holding period of 3-5 years is recommended to capture the benefits of dividend reinvestment and potential business cycle recovery. Short-term investors should look elsewhere for momentum.